| Oncology and pharmacogenetics in 2007. | |
| | |
MedLine Citation:
|
PMID: 17187504 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Justin Stebbing is a member of the Royal College of Physicians, American Board of Internal Medicine and the Royal College of Pathologists. Originally, Justin trained in medicine at Trinity College Oxford (Oxford, UK), obtaining a triple first class degree. After completion of junior doctor posts in Oxford, he undertook a residency (junior doctor) training at The Johns Hopkins Hospital (MD, USA), before returning to London to continue his training in oncology at The Royal Marsden. Justin then undertook a PhD, funded by the medical research council, investigating the interplay between the immune system and cancer. Specifically, the role of heat shock proteins in tumorigenesis was examined, leading to the development of a cancer vaccine that is currently in clinical trials. Justin has published over 200 papers and book chapters, in journals such as the Lancet, New England Journal, Blood, the Journal of Clinical Oncology and Annals of Internal Medicine, the majority as first or last author. They mainly focus on early and late stage trials of new drugs, mechanisms of disease and prognostic indicators. He is on the editorial board of a number of journals and regularly serves as a referee. Justin's main focus is now in breast cancer, and helping patients with early and late stage disease get better. |
| | |
Authors:
|
Justin Stebbing |
Related Documents
:
|
8291504 - Effect of a simple ambulatory experience on career choice and attitudes of medical stud... 8135454 - What is the oslerian tradition? 3527014 - One hundred years of american internal medicine. a view from the inside. 8207164 - Objectives to direct the training of emergency medicine residents on off-service rotati... 9490064 - Modes of action on cotton and bacterial cellulose of a homologous endoglucanase-exogluc... 20831924 - The use of local anesthetic agents in medicine. |
Publication Detail:
|
Type: Interview |
Journal Detail:
|
Title: Pharmacogenomics Volume: 8 ISSN: 1744-8042 ISO Abbreviation: Pharmacogenomics Publication Date: 2007 Jan |
Date Detail:
|
Created Date: 2006-12-25 Completed Date: 2007-12-03 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100897350 Medline TA: Pharmacogenomics Country: England |
Other Details:
|
Languages: eng Pagination: 17-9 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antineoplastic Agents
/
administration & dosage Drug Delivery Systems / methods, trends Humans Medical Oncology / methods, trends* Neoplasms / drug therapy, genetics Pharmacogenetics / methods, trends* |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Graying anatomy? Toward molecular tumor characterization.
Next Document: Cardiovascular therapy and pharmacogenetics in 2007.